AAAAAA
Results: 51-66/66
Authors:
BROWER V
Citation: V. Brower, COMPANIES AIM AT NEW HIV TARGETS, Nature biotechnology, 14(9), 1996, pp. 1079-1079
Authors:
BROWER V
Citation: V. Brower, COMBATING CONSUMPTION, Nature biotechnology, 14(9), 1996, pp. 1097-1099
Authors:
BROWER V
Citation: V. Brower, HONEYMOON NOT YET OVER FOR PHARMA-BIOTECH DEALS, Nature biotechnology, 14(8), 1996, pp. 940-940
Authors:
BROWER V
Citation: V. Brower, MYOTROPHIN APPROVED BY A WHISKER, Nature biotechnology, 14(7), 1996, pp. 811-811
Authors:
BROWER V
Citation: V. Brower, RIFKIN MARSHALS FEMINISTS AGAINST GENE PATENTS, Nature biotechnology, 14(7), 1996, pp. 814-815
Authors:
BROWER V
Citation: V. Brower, PPL FLOATS IPO AS COMPANIES CONSIDER TRANSGENIC SWITCH, Nature biotechnology, 14(6), 1996, pp. 692-692
Authors:
BROWER V
Citation: V. Brower, GENZYME LEADS TRANSGENICS PACK, Nature biotechnology, 14(6), 1996, pp. 692-692
Authors:
BROWER V
Citation: V. Brower, STENT STATISTICS, Nature biotechnology, 14(4), 1996, pp. 422-422
Authors:
BROWER V
Citation: V. Brower, EARLY-STAGE RESTINOSIS THERAPEUTICS MOVE AHEAD, Nature biotechnology, 14(4), 1996, pp. 422
Authors:
BROWER V
Citation: V. Brower, STENTS AND BIOLOGY COMBINATION FOR RESTENOSIS, Nature biotechnology, 14(4), 1996, pp. 422-422
Authors:
BROWER V
Citation: V. Brower, TEVAS MS DRUG EDGES TO THE MARKET, Nature biotechnology, 14(11), 1996, pp. 1536-1536
Authors:
BROWER V
Citation: V. Brower, ECOGEN-ISRAEL GETS 2ND APPROVAL, Nature biotechnology, 14(10), 1996, pp. 1212-1212
Authors:
BROWER V
Citation: V. Brower, FINDING DEATH ONLINE, Nature medicine, 2(9), 1996, pp. 954-954
Authors:
BROWER V
Citation: V. Brower, CANCER SURVIVORS GET NEW OFFICE, Nature medicine, 2(8), 1996, pp. 836-836
Authors:
BROWER V
Citation: V. Brower, QUINLAN,KAREN,ANN LEGACY OF CONTROVERSY, Nature medicine, 2(6), 1996, pp. 617-618
Authors:
BROWER V
Citation: V. Brower, CONFLICT-OF-INTEREST REDUX, Nature medicine, 2(10), 1996, pp. 1057-1058